Quang X Pham, Chairman, CEO and Interim CFO at Cadrenal Therapeutics, sold CVKD on Jun 8, 2026
Data as of Oct 27
▼ SELL$25.8K5,893 shares at $4.38Quang X Pham Chairman, CEO and Interim CFOCVKD Cadrenal Therapeutics, Inc.
- Traded
- Jun 8, 2026
- Disclosed
- Jun 10, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
CVKD since disclosure
−77.2%
after the sale
Similar stocks (XLV) since disclosure
+17.2%
XLV — its sector index fund
Change in closing price from Jun 10, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLQuang X Pham Chairman, CEO and Interim CFOCVKD Cadrenal Therapeutics, Inc.$14.7Kdisclosed Jun 10 · filed the same day
- ▼ SELLQuang X Pham Chairman, CEO and Interim CFOCVKD Cadrenal Therapeutics, Inc.$52.7Kdisclosed Jun 10 · filed 1 day after the trade